Select Asset Management & Trust’s Gilead Sciences GILD Stock Holding History

Select Asset Management & Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,000	Closed	-$1.17M	–	34
2015 Q2	$1.17M	Sell	10,000 -20,000	-67%	-$2.19M	1.02%	19
2015 Q1	$2.94M	Buy	+30,000	New	+$3.05M	2.28%	16

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Select Asset Management & Trust's GILD Position: Q3 2015 in Review

Select Asset Management & Trust sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 10,000 shares — an estimated $1.17M sold.

Select Asset Management & Trust first reported a position in GILD in Q1 2015 and held it in 2 quarters. The position peaked at $2.94M in Q1 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Select Asset Management & Trust reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
Select Asset Management & Trust sold 10,000 Gilead Sciences shares in Q3 2015, an estimated $1.17M.
Select Asset Management & Trust first reported a position in Gilead Sciences in Q1 2015 and held it in 2 quarters.
Select Asset Management & Trust's Gilead Sciences position peaked at $2.94M in Q1 2015.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Select Asset Management & Trust's 13F filing for Q3 2015, filed 28 Oct 2015.